Sign inGet started

Hyep Ivan

Insider CIK 2034668 · BCAX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-08-102026-08-1212,500— $026,336SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-08-102026-08-1212,500$27.97 $349.6K129,855SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-08-102026-08-1212,500$3.79 $47.4K142,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-08-102026-08-1212,500— $026,336SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-08-102026-08-1212,500$27.97 $349.6K129,855SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-08-102026-08-1212,500$3.79 $47.4K142,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-07-082026-07-10908— $038,836SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-07-082026-07-1011,592— $058,992SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-082026-07-104,413$29.82 $131.6K130,685SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-082026-07-1022,757$28.60 $650.9K135,098SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-07-082026-07-1012,500$3.79 $47.4K157,855SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-07-082026-07-10830$30.31 $25.2K129,855SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-05-212026-05-269,200— $070,584SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-05-212026-05-269,200$20.42 $187.9K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-05-212026-05-269,200$3.79 $34.9K154,555SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-04-212026-04-229,200— $039,744SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-04-212026-04-229,200$3.79 $34.9K154,555SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-04-212026-04-229,200$23.00 $211.6K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-03-232026-03-249,200— $048,944SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-232026-03-249,200$18.52 $170.4K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-03-232026-03-249,200$3.79 $34.9K154,555SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-03-042026-03-052,963— $079,784SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-03-042026-03-052,963$3.79 $11.2K148,318SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-042026-03-052,963$18.25 $54.1K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-03-032026-03-057,318— $058,144SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-03-032026-03-056,237— $082,747SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-03-032026-03-057,318$3.79 $27.7K152,673SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-03-032026-03-056,237$3.79 $23.6K158,910SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-03-032026-03-0513,555$18.22 $247.0K145,355SEC↗
BCAX Bicara Therapeutics Inc. A Award deriv2026-02-022026-02-04125,000— $0125,000SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2026-01-222026-01-261,882— $065,462SEC↗
BCAX Bicara Therapeutics Inc. S Sale2026-01-222026-01-261,882$18.15 $34.2K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2026-01-222026-01-261,882$3.79 $7.1K147,237SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-12-222025-12-239,200— $088,984SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-12-222025-12-239,200$18.31 $168.5K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-12-222025-12-239,200$3.79 $34.9K154,555SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-11-242025-11-2517,795— $098,184SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-11-242025-11-2517,795$18.55 $330.1K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-11-242025-11-2517,795$3.79 $67.4K163,150SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-11-212025-11-25605— $0115,979SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-11-212025-11-25605$18.15 $11.0K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-11-212025-11-25605$3.79 $2.3K145,960SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-092025-10-106,415— $0116,584SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-092025-10-106,415$18.23 $116.9K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-092025-10-106,415$3.79 $24.3K151,770SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-082025-10-085,627— $0122,999SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-082025-10-085,627$3.79 $21.3K150,982SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-082025-10-085,627$18.21 $102.5K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-072025-10-0818,244— $0128,626SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-072025-10-0818,244$3.79 $69.1K163,599SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-072025-10-0818,244$18.22 $332.4K145,355SEC↗
BCAX Bicara Therapeutics Inc. M Exercise deriv2025-10-062025-10-086,514— $0146,870SEC↗
BCAX Bicara Therapeutics Inc. M Exercise2025-10-062025-10-086,514$3.79 $24.7K151,869SEC↗
BCAX Bicara Therapeutics Inc. S Sale2025-10-062025-10-086,514$18.17 $118.4K145,355SEC↗